Medspace Solutions Limited - Period Ending 2019-03-31

Medspace Solutions Limited - Period Ending 2019-03-31


Medspace Solutions Limited 07960162 false 2018-04-01 2019-03-31 2019-03-31 The principal activity of the company is Design and Installation of Specialist Medical Equipment. Digita Accounts Production Advanced 6.24.8820.0 Software true 07960162 2018-04-01 2019-03-31 07960162 2019-03-31 07960162 bus:OrdinaryShareClass1 2019-03-31 07960162 core:CurrentFinancialInstruments 2019-03-31 07960162 core:CurrentFinancialInstruments core:WithinOneYear 2019-03-31 07960162 core:Non-currentFinancialInstruments 2019-03-31 07960162 core:Non-currentFinancialInstruments core:AfterOneYear 2019-03-31 07960162 core:FurnitureFittingsToolsEquipment 2019-03-31 07960162 core:MotorVehicles 2019-03-31 07960162 core:OtherPropertyPlantEquipment 2019-03-31 07960162 bus:SmallEntities 2018-04-01 2019-03-31 07960162 bus:AuditExemptWithAccountantsReport 2018-04-01 2019-03-31 07960162 bus:FullAccounts 2018-04-01 2019-03-31 07960162 bus:SmallCompaniesRegimeForAccounts 2018-04-01 2019-03-31 07960162 bus:RegisteredOffice 2018-04-01 2019-03-31 07960162 bus:Director1 2018-04-01 2019-03-31 07960162 bus:Director2 2018-04-01 2019-03-31 07960162 bus:Director3 2018-04-01 2019-03-31 07960162 bus:OrdinaryShareClass1 2018-04-01 2019-03-31 07960162 bus:PrivateLimitedCompanyLtd 2018-04-01 2019-03-31 07960162 bus:Agent1 2018-04-01 2019-03-31 07960162 core:CommercialMotorVehicles 2018-04-01 2019-03-31 07960162 core:FurnitureFittings 2018-04-01 2019-03-31 07960162 core:FurnitureFittingsToolsEquipment 2018-04-01 2019-03-31 07960162 core:MotorVehicles 2018-04-01 2019-03-31 07960162 core:OtherPropertyPlantEquipment 2018-04-01 2019-03-31 07960162 core:PlantMachinery 2018-04-01 2019-03-31 07960162 countries:AllCountries 2018-04-01 2019-03-31 07960162 2018-03-31 07960162 core:FurnitureFittingsToolsEquipment 2018-03-31 07960162 core:MotorVehicles 2018-03-31 07960162 core:OtherPropertyPlantEquipment 2018-03-31 07960162 2017-04-01 2018-03-31 07960162 2018-03-31 07960162 bus:OrdinaryShareClass1 2018-03-31 07960162 core:CurrentFinancialInstruments 2018-03-31 07960162 core:CurrentFinancialInstruments core:WithinOneYear 2018-03-31 07960162 core:Non-currentFinancialInstruments 2018-03-31 07960162 core:Non-currentFinancialInstruments core:AfterOneYear 2018-03-31 07960162 core:FurnitureFittingsToolsEquipment 2018-03-31 07960162 core:MotorVehicles 2018-03-31 07960162 core:OtherPropertyPlantEquipment 2018-03-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 07960162

Medspace Solutions Limited

Annual Report and Unaudited Financial Statements

for the Year Ended 31 March 2019

First Class Accounting Limited
91A Church Lane
Bulphan
Upminster
RM14 3TR


 

 

Medspace Solutions Limited

Contents

Company Information

1

Accountants' Report

2

Balance Sheet

3 to 4

Notes to the Unaudited Financial Statements

5 to 12

 

Medspace Solutions Limited

Company Information

Directors

S M Wolf

A Fincher

Mrs L E Smith

Registered office

91A Church Lane
Bulphan
Upminster
RM14 3TR

Accountants

First Class Accounting Limited
91A Church Lane
Bulphan
Upminster
RM14 3TR

 

Chartered Accountants' Report to the Board of Directors on the Preparation of the Unaudited Statutory Accounts of
Medspace Solutions Limited
for the Year Ended 31 March 2019

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the accounts of Medspace Solutions Limited for the year ended 31 March 2019 as set out on pages 3 to 12 from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed at
http://www.icaew.com/en/members/regulations-standards-and-guidance/.

This report is made solely to the Board of Directors of Medspace Solutions Limited, as a body, in accordance with the terms of our engagement letter. Our work has been undertaken solely to prepare for your approval the accounts of Medspace Solutions Limited and state those matters that we have agreed to state to the Board of Directors of Medspace Solutions Limited, as a body, in this report in accordance with ICAEW Technical Release 07/16 AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Medspace Solutions Limited and its Board of Directors as a body for our work or for this report.

It is your duty to ensure that Medspace Solutions Limited has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and profit of Medspace Solutions Limited. You consider that Medspace Solutions Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the accounts of Medspace Solutions Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory accounts.

......................................

First Class Accounting Limited
91A Church Lane
Bulphan
Upminster
RM14 3TR

23 December 2019

 

Medspace Solutions Limited

(Registration number: 07960162)
Balance Sheet as at 31 March 2019

Note

2019
£

2018
£

Fixed assets

 

Tangible assets

4

118,398

140,277

Current assets

 

Stocks

5

32,717

22,587

Debtors

6

312,346

175,451

Cash at bank and in hand

 

-

11,933

 

345,063

209,971

Creditors: Amounts falling due within one year

7

(280,588)

(192,122)

Net current assets

 

64,475

17,849

Total assets less current liabilities

 

182,873

158,126

Creditors: Amounts falling due after more than one year

7

(95,073)

(109,718)

Net assets

 

87,800

48,408

Capital and reserves

 

Called up share capital

8

300

300

Profit and loss account

87,500

48,108

Total equity

 

87,800

48,408

For the financial year ending 31 March 2019 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the Profit and Loss Account has been taken.

 

Medspace Solutions Limited

(Registration number: 07960162)
Balance Sheet as at 31 March 2019

Approved and authorised by the Board on 23 December 2019 and signed on its behalf by:
 

.........................................

A Fincher
Director

 

Medspace Solutions Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2019

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
91A Church Lane
Bulphan
Upminster
RM14 3TR

These financial statements were authorised for issue by the Board on 23 December 2019.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A - 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006.

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

 

Medspace Solutions Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2019

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Tangible assets

Tangible assets are stated in the statement of financial position at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Fixtures, fittings and equipment

33% straight line

Motor vehicles

33% straight line

Other tangible assets

20% straight line

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.

The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.

 

Medspace Solutions Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2019

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the Profit and Loss Account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

 

Medspace Solutions Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2019

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 15 (2018 - 10).

 

Medspace Solutions Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2019

4

Tangible assets

Furniture, fittings and equipment
 £

Motor vehicles
 £

Other tangible assets
£

Total
£

Cost or valuation

At 1 April 2018

35,811

22,354

159,941

218,106

Additions

27,892

-

2,371

30,263

Disposals

-

(12,743)

-

(12,743)

At 31 March 2019

63,703

9,611

162,312

235,626

Depreciation

At 1 April 2018

19,922

18,583

39,324

77,829

Charge for the year

14,095

3,771

34,276

52,142

Eliminated on disposal

-

(12,743)

-

(12,743)

At 31 March 2019

34,017

9,611

73,600

117,228

Carrying amount

At 31 March 2019

29,686

-

88,712

118,398

At 31 March 2018

15,889

3,771

120,617

140,277

5

Stocks

2019
£

2018
£

Raw materials and consumables

32,717

22,587

6

Debtors

2019
£

2018
£

Trade debtors

308,131

163,036

Other debtors

4,215

12,415

312,346

175,451

7

Creditors

Creditors: amounts falling due within one year

 

Medspace Solutions Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2019

Note

2019
£

2018
£

Due within one year

 

Loans and borrowings

9

94,461

51,518

Trade creditors

 

91,735

99,899

Taxation and social security

 

63,572

22,319

Other creditors

 

30,820

18,386

 

280,588

192,122

Creditors: amounts falling due after more than one year

Note

2019
£

2018
£

Due after one year

 

Loans and borrowings

9

95,073

109,718

8

Share capital

Allotted, called up and fully paid shares

 

2019

2018

 

No.

£

No.

£

Ordinary shares of £1 each

300

300

300

300

         

9

Loans and borrowings

2019
£

2018
£

Non-current loans and borrowings

Other borrowings

95,073

109,718

 

Medspace Solutions Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2019

2019
£

2018
£

Current loans and borrowings

Bank borrowings

13,946

1,279

Other borrowings

80,515

50,239

94,461

51,518

10

Dividends

   

2019

 

2018

   

£

 

£

Interim dividend of £162 (2018 - £166) per ordinary share

 

48,614

 

49,758

         

11

Related party transactions

Key management compensation

2019
£

2018
£

Salaries and other short term employee benefits

25,272

24,492

Directors' remuneration

The directors' remuneration for the year was as follows:

2019
£

2018
£

Remuneration

25,272

22,900

Dividends paid to directors

 

Medspace Solutions Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2019

 

2019
£

2018
£

S M Wolf

   

23,524

22,622

     
         

A Fincher

   

17,100

19,348

     
         

Mrs L E Smith

   

7,990

5,688